N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide

C275H286N22O37S11 — CID 161192214

IUPACN-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide
SMILESCc1ccc(S(=O)(=O)NC2CCC[C@H](N3c4ccccc4COc4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCCC(N3c4ccccc4Oc4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCCC(n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@@H](N3c4ccccc4Oc4ccccc43)[C@@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@@H](n3c4ccccc4c4ccccc43)[C@@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@H](N3c4ccccc4Oc4ccccc43)[C@@H]2O)cc1.O=S(=O)(N[C@@H]1CCC[C@H](n2c3ccccc3c3ccccc32)[C@H]1O)c1ccccc1
InChIInChI=1S/C26H28N2O4S.3C25H26N2O4S.6C25H26N2O3S.C24H24N2O3S/c1-18-13-15-20(16-14-18)33(30,31)27-21-8-6-11-24(26(21)29)28-22-9-3-2-7-19(22)17-32-25-12-5-4-10-23(25)28;3*1-17-13-15-18(16-14-17)32(29,30)26-19-7-6-10-22(25(19)28)27-20-8-2-4-11-23(20)31-24-12-5-3-9-21(24)27;6*1-17-13-15-18(16-14-17)31(29,30)26-21-9-6-12-24(25(21)28)27-22-10-4-2-7-19(22)20-8-3-5-11-23(20)27;27-24-20(25-30(28,29)17-9-2-1-3-10-17)13-8-16-23(24)26-21-14-6-4-11-18(21)19-12-5-7-15-22(19)26/h2-5,7,9-10,12-16,21,24,26-27,29H,6,8,11,17H2,1H3;3*2-5,8-9,11-16,19,22,25-26,28H,6-7,10H2,1H3;6*2-5,7-8,10-11,13-16,21,24-26,28H,6,9,12H2,1H3;1-7,9-12,14-15,20,23-25,27H,8,13,16H2/t21?,24-,26-;19-,22?,25+;19-,22+,25+;19-,22-,25+;21-,24?,25+;5*21-,24+,25+;20-,23+,24+/m01001111101/s1
InChIKeyUTWHJHCKUUPXTN-XSQZIEEHSA-N
MW4844.17 g/mol
LogP49.23
Rot. Bonds44

About N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide

N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide (PubChem CID 161192214) has the molecular formula C275H286N22O37S11 and a molecular weight of 4844.17 g/mol. Its IUPAC name is N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide.

Molecular Properties

Compound NameN-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide
PubChem CID161192214
Molecular FormulaC275H286N22O37S11
Molecular Weight4844.17 g/mol
Exact Mass4839.81
IUPAC NameN-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide
SMILESCc1ccc(S(=O)(=O)NC2CCC[C@H](N3c4ccccc4COc4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCCC(N3c4ccccc4Oc4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCCC(n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@@H](N3c4ccccc4Oc4ccccc43)[C@@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@@H](n3c4ccccc4c4ccccc43)[C@@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@H](N3c4ccccc4Oc4ccccc43)[C@@H]2O)cc1.O=S(=O)(N[C@@H]1CCC[C@H](n2c3ccccc3c3ccccc32)[C@H]1O)c1ccccc1
InChIInChI=1S/C26H28N2O4S.3C25H26N2O4S.6C25H26N2O3S.C24H24N2O3S/c1-18-13-15-20(16-14-18)33(30,31)27-21-8-6-11-24(26(21)29)28-22-9-3-2-7-19(22)17-32-25-12-5-4-10-23(25)28;3*1-17-13-15-18(16-14-17)32(29,30)26-19-7-6-10-22(25(19)28)27-20-8-2-4-11-23(20)31-24-12-5-3-9-21(24)27;6*1-17-13-15-18(16-14-17)31(29,30)26-21-9-6-12-24(25(21)28)27-22-10-4-2-7-19(22)20-8-3-5-11-23(20)27;27-24-20(25-30(28,29)17-9-2-1-3-10-17)13-8-16-23(24)26-21-14-6-4-11-18(21)19-12-5-7-15-22(19)26/h2-5,7,9-10,12-16,21,24,26-27,29H,6,8,11,17H2,1H3;3*2-5,8-9,11-16,19,22,25-26,28H,6-7,10H2,1H3;6*2-5,7-8,10-11,13-16,21,24-26,28H,6,9,12H2,1H3;1-7,9-12,14-15,20,23-25,27H,8,13,16H2/t21?,24-,26-;19-,22?,25+;19-,22+,25+;19-,22-,25+;21-,24?,25+;5*21-,24+,25+;20-,23+,24+/m01001111101/s1
InChIKeyUTWHJHCKUUPXTN-XSQZIEEHSA-N
XLogP49.23
TPSA814.79 Ų
H-Bond Donors22
H-Bond Acceptors48
Rotatable Bonds44
Heavy Atoms345
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004844.17
LogP ≤ 549.23
H-Bond Donors ≤ 522
H-Bond Acceptors ≤ 1048

Analyze N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-propanoylbenzenesulfonamide
CID 155077305
N-[(1S,2S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]methanesulfonamide
CID 161459830
2-carbazol-9-yl-6-[(N-methyl-S-phenylsulfonimidoyl)amino]cyclohexan-1-ol
CID 166592581
N-[(3S,4S,5R)-5-carbazol-9-yl-4-hydroxyoxan-3-yl]-4-methylbenzenesulfonamide;bis(N-[(3R,4R,5S)-4-hydroxy-5-phenoxazin-10-yloxan-3-yl]-3-methylbenzenesulfonamide);N-[(3R,4R,5S)-4-hydroxy-5-phenoxazin-10-yl-1-pyrimidin-2-ylpiperidin-3-yl]-4-methylbenzenesulfonamide;N-[(3R,4R,5S)-4-hydroxy-5-phenoxazin-10-yl-1-pyrimidin-4-ylpiperidin-3-yl]-4-methylbenzenesulfonamide
CID 159416765
N-[(3R,4R,5S)-4-hydroxy-5-phenoxazin-10-yl-1-pyrimidin-4-ylpiperidin-3-yl]-4-methylbenzenesulfonamide
CID 159416768
2-amino-6-phenoxazin-10-ylcyclohexan-1-ol;N,N-diethylethanamine;N-(2-hydroxy-3-phenoxazin-10-ylcyclohexyl)-4-(trifluoromethoxy)benzenesulfonamide;4-methylbenzenesulfonyl chloride
CID 157421463
N-[2-hydroxy-3-[2-(trifluoromethyl)phenoxazin-10-yl]cyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide
CID 123229562
N-[(1R,2R)-3-(3-fluorocarbazol-9-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide
CID 134402065
4-chloro-N-[(2R)-3-(3,6-dichlorocarbazol-9-yl)-2-hydroxycyclohexyl]benzenesulfonamide
CID 155061442
N-[(1R,2R,3S)-3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide
CID 118374266
N-[(2R)-3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide
CID 146830114
4-amino-N-[(3R,4R,5S)-4-hydroxy-5-phenoxazin-10-yloxan-3-yl]benzenesulfonamide
CID 126673697

Frequently Asked Questions

What is the IUPAC name of N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide?
The IUPAC name of N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide (CID 161192214) is N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide.
What is the SMILES notation for N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide?
The canonical SMILES for N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide is Cc1ccc(S(=O)(=O)NC2CCC[C@H](N3c4ccccc4COc4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCCC(N3c4ccccc4Oc4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCCC(n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@@H]2CCC[C@H](n3c4ccccc4c4ccccc43)[C@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@@H](N3c4ccccc4Oc4ccccc43)[C@@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@@H](n3c4ccccc4c4ccccc43)[C@@H]2O)cc1.Cc1ccc(S(=O)(=O)N[C@H]2CCC[C@H](N3c4ccccc4Oc4ccccc43)[C@@H]2O)cc1.O=S(=O)(N[C@@H]1CCC[C@H](n2c3ccccc3c3ccccc32)[C@H]1O)c1ccccc1.
What is the InChIKey of N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide?
The InChIKey is UTWHJHCKUUPXTN-XSQZIEEHSA-N. The full InChI is InChI=1S/C26H28N2O4S.3C25H26N2O4S.6C25H26N2O3S.C24H24N2O3S/c1-18-13-15-20(16-14-18)33(30,31)27-21-8-6-11-24(26(21)29)28-22-9-3-2-7-19(22)17-32-25-12-5-4-10-23(25)28;3*1-17-13-15-18(16-14-17)32(29,30)26-19-7-6-10-22(25(19)28)27-20-8-2-4-11-23(20)31-24-12-5-3-9-21(24)27;6*1-17-13-15-18(16-14-17)31(29,30)26-21-9-6-12-24(25(21)28)27-22-10-4-2-7-19(22)20-8-3-5-11-23(20)27;27-24-20(25-30(28,29)17-9-2-1-3-10-17)13-8-16-23(24)26-21-14-6-4-11-18(21)19-12-5-7-15-22(19)26/h2-5,7,9-10,12-16,21,24,26-27,29H,6,8,11,17H2,1H3;3*2-5,8-9,11-16,19,22,25-26,28H,6-7,10H2,1H3;6*2-5,7-8,10-11,13-16,21,24-26,28H,6,9,12H2,1H3;1-7,9-12,14-15,20,23-25,27H,8,13,16H2/t21?,24-,26-;19-,22?,25+;19-,22+,25+;19-,22-,25+;21-,24?,25+;5*21-,24+,25+;20-,23+,24+/m01001111101/s1.
What are the key properties of N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide?
N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide has a molecular weight of 4844.17 g/mol, XLogP of 49.23, 44 rotatable bonds, 22 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R,2R,3S)-3-(6H-benzo[c][1,5]benzoxazepin-11-yl)-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]benzenesulfonamide;N-[(1S,2S,3R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;tetrakis(N-[(1R,2R,3S)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide);N-[(1R,2R)-3-carbazol-9-yl-2-hydroxycyclohexyl]-4-methylbenzenesulfonamide;N-[(1R,2R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide;N-[(1S,2S,3R)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-methylbenzenesulfonamide is sourced from PubChem (CID 161192214), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).